Axsome Therapeutics (AXSM) Share-based Compensation Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 21.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.89% |
| Dec 31, 2025 | -15.52% |
| Sep 30, 2025 | 1,259.38% |
| Jun 30, 2025 | 1,242.92% |
| Mar 31, 2025 | 1,353.01% |
| Dec 31, 2024 | 55.12% |
| Sep 30, 2024 | 55.82% |
| Jun 30, 2024 | 57.66% |
| Mar 31, 2024 | 75.56% |
| Dec 31, 2023 | 49.99% |
| Sep 30, 2023 | 78.69% |
| Jun 30, 2023 | 130.51% |
| Mar 31, 2023 | 82.38% |
| Dec 31, 2022 | 137.51% |
| Sep 30, 2022 | -80.04% |
| Jun 30, 2022 | -77.47% |
| Mar 31, 2022 | -81.78% |
| Dec 31, 2021 | 155.52% |
| Sep 30, 2021 | 144.30% |
| Jun 30, 2021 | 125.69% |
| Mar 31, 2021 | 91.11% |
| Dec 31, 2020 | 118.56% |
| Sep 30, 2020 | 94.81% |
| Jun 30, 2020 | 39.04% |
| Mar 31, 2020 | 47.59% |
| Dec 31, 2019 | 86.36% |
| Sep 30, 2019 | 36.12% |
| Jun 30, 2019 | 22.61% |
| Mar 31, 2019 | 24.17% |
| Dec 31, 2018 | 24.64% |
| Sep 30, 2018 | 2.87% |
| Jun 30, 2018 | 36.80% |
| Mar 31, 2018 | 92.65% |